Free EMR Newsletter Want to receive the latest news on EMR, Meaningful Use, ARRA and Healthcare IT sent straight to your email? Join thousands of healthcare pros who subscribe to EMR and EHR for FREE!

Digital Therapeutics

Here’s a new term for you to consider: digital therapeutics. I guess I could add it to the list I polled about earlier: Digital Health, Connected Health, Wireless Health, Mobile Health, and Telehealth. By the way, the poll results are showing a mix basket when it comes to using these terms. Digital Health leads the way with mobile health following pretty closely behind and connected health with quite a few votes.

I don’t think adding digital therapeutics to the ring helps to clear up the confusion of terms, but I think it can open us open to a new way of thinking when it comes to how we use digital in healthcare. I’ve long loved the idea of prescribing an app and digital therapeutics is along those same lines. Can we prescribe a digital therapy that will help improve a patient?

Since we’re throwing out new terms that stretch our thinking, how about the ideas of digital chemistry and digital biology. I like these because they suggest a rigor in their study and understanding like you might see in chemistry and biology. I think it’s fair to say that the very best healthcare IT companies are going to be digging into the digital chemistry and digital biology world.

Once you start digging into these areas though, you better be ready for the FDA regulation that comes with therapeutics. I’ve written quite a bit about EHR and FDA regulation and this is why I don’t think EHR vendors will be digging into this type of digital therapeutics. Instead, I think the EHR will stick to being the database of healthcare.

In a recent video interview I did with Alan Portela, he made a really good point about the transition to really smart mobile health technologies that start to suggest treatment (some might call that a shift to digital therapeutics). The problem with many mobile health technologies that have avoided FDA clearance is that they won’t be able to do digital therapeutics. It will take a company that’s FDA cleared and understands that process to put these type of digital “treatments” into place.

I’m excited about the potential for digital therapeutics (or whatever word you prefer). This will change the way we look at healthcare and that will be a very good thing.

May 22, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 14 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John launched two new companies: InfluentialNetworks.com and Physia.com, and is an advisor to docBeat. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and Google Plus. Healthcare Scene can be found on Google+ as well.

Does adding all these EHR and other tech add or subtract to healthcare?

Such a compelling and tough question to consider. Let me repeat it again so you can let it roll around in your mind for a minute:

Does adding all these EHR and other tech add or subtract to healthcare?

This was one of the off hand comments I heard someone make in their presentation at TEDMED and I think it’s a serious question that every EHR company and healthcare IT vendor should consider.

The simple answer to the question is that some companies add to healthcare and some take away from healthcare. That’s just the nature of markets. However, there’s a deeper part of the question which fundamentally asks if the shift to electronic is helping healthcare or hurting it.

As I’ve mentioned previously, at my core I believe that technology has an overall positive impact on any industry. In my heart I believe that technology has the potential to improve most things.

My fear with the above question is whether we’re implementing the right technology that will help us have a positive impact on healthcare or whether we’re currently implementing dated technology which will set us back for years to come.

I got in a heated discussion today on LinkedIn about the MUMPS database. A HUGE portion of healthcare is built on the back of MUMPS. Nothing against MUMPS (although it does sound like an STD), but is it going to be powerful enough to “add” to healthcare or will we reach a point that its limitations start subtracting from what could be possible?

I don’t necessarily want this post to become a MUMPS pros and cons post, but I think it’s a great illustration of why I’m reticent to say that the technology foundation that healthcare is building today is providing a platform for an amazing healthcare IT future.

On the other side of the spectrum is the plethora of smart phone apps and devices in healthcare. You can’t tell me that the Alivecor device or AirStrip’s work in the mobile field isn’t incredibly exciting. They’re leveraging the latest technology in a beautiful way.

One challenge we do face is the HUGE number of EMR companies and mobile health apps. With so many companies, we’re bound to have a healthcare software graveyard soon. Hopefully the companies we find in the graveyard are those who were subtracting from healthcare instead of adding to it. Unfortunately, that’s still just a hope and may not be the reality.

Many of our newer readers might not be familiar with my reference to Jabba the Hutt EHRs. The concept would seem to apply well to this post. For those not familiar with the concept, Jabba the Hutt was a really powerful individual, but it’s safe to say that he wasn’t very nimble. Does this sound a bit like some of the healthcare IT and EHR companies that dominate the market today?

Maybe I’m wrong, but the nimble innovative companies are the ones that usually add the most to healthcare versus subtracting. Luckily history is on my side. I’m just not sure we have enough Princess Leia companies that are in a position to wrap their chain around the neck of Jabba the Hutt companies.

I’ll let you decide which companies you believe add to healthcare and which ones subtract from healthcare. Although, I think we’d all benefit if every company focused on adding to healthcare.

May 7, 2013 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 14 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John launched two new companies: InfluentialNetworks.com and Physia.com, and is an advisor to docBeat. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and Google Plus. Healthcare Scene can be found on Google+ as well.

Could Patent Conflicts Choke mHealth Growth?

This week I caught a very interesting piece in MobiHealthNews which took a look at the possibility that the mHealth world is ripe for patent clashes.

Orion Armon, an attorney with Cooley LLP’s IP litigation practice, notes that companies in medical device, computer, networking and communications markets are busily patenting mHealth innovations, and that sooner or later, these patents will overlap.  The result: nasty turf battles which cost everyone involved boatloads of time and money.

While the number of patent lawsuits currently being filed in these industries is nowhere near the levels seen in say, the smartphone and computer  business, a few significant cases have emerged, Armon reports:

  • CardioNet filed lawsuits against MedNet Healthcare, MedTel 24, Rhythm Watch, AMI Cardiac Monitoring, ScottCare, and Ambucore Health Solutions;
  • Robert Bosch Healthcare filed lawsuits against ExpressMD, MedApps, Waldo Health, and Cardiocom; and
  • BodyMedia filed a lawsuit against Basis Science.

But that’s just the tip of the iceberg. Consider the patent ambitions of Airstrip, a tech vendor offering a mobile patient monitoring platform. The company’s President and Chief Medical Officer, Dr. Cameron Powell, told MobiHealthNews that his company’s patents cover “taking any type of physiologic data—whether that’s from a sensor in the shoe, a home monitor, a blood pressure cuff, or a monitor in the hospital—and then re-rendering it on a native or HTML5 application on a mobile device.”  (My jaw dropped when I read that one.)

Since that interview, Airstrip has filed a lawsuit against mVisum Inc. alleging that four of the other vendor’s products infringe its patent.  It’s asking the court for an injunction barring future infringement, treble damages and attorneys’ fees.  These are standard provisions in a patent lawsuit, but from where I sit they’re pretty intimidating, and if the injunction is ordered mVisum has a heck of a battle on its hands.

As provider interest in mHealth applications continues to expand, I can only imagine that the patent battles are going to get uglier and more widespread.  It’s only logical, given the explosion of innovation we’re seeing in this space. But I do hope that patent wars don’t slow the introduction of new products too much at such a critical time in the mHealth industry’s growth.

November 2, 2012 I Written By

Anne Zieger is veteran healthcare consultant and analyst with 20 years of industry experience. Zieger formerly served as editor-in-chief of FierceHealthcare.com and her commentaries have appeared in dozens of international business publications, including Forbes, Business Week and Information Week. She has also contributed content to hundreds of healthcare and health IT organizations, including several Fortune 500 companies. Contact her at @annezieger on Twitter.